Organ-AI | Breakthrough Diagnostics Imaging

Our Mission at Organ-AI  -   To revolutionize diagnostics with a fast, accurate, non-ionizing, non-invasive alternative to biopsy for human tissue assessment

• Only 27 percent waiting for a kidney transplant actually receive it. 

• 13 people die daily while waiting.

• Transplant teams discard 2/5 kidneys deemed imperfect because of biopsy results- an inconsistent and inaccurate method. 

• US market is 1.75 B USD and this is only for the organ diagnostics application. Our patent pending technology is limitless. 

OUR 8 SECOND SOLUTION -  Spectral Imaging with Near Infrared Light, plus sensor technology and Deep Learning.

Vibrant, high resolution 3 D data assesses color for blood flow, chemical composition up to 6 cm below the surface of intact skin.

Deep Learning software assesses the rich imaging against 1000s of stored digital images to score the organ & predict graft outcomes.

• We are raising pre-seed funding to establish preliminary infrastructure, design and build our prototype hardware, and begin working on the AI software and platform,  pay attorneys for the second stage of patenting and another attorney to guide the FDA clearance process. 

• I have a degree from Vanderbilt University in Leadership and I am nearly done with my Ph.D. at NC State.

• My mentors and advisors range from technical experts in bioengineering, photonics, and quantum, B2B, SaaS, and start-up serial entrepreneurs, 

• Help us help the world with Organ-AI -- Breakthrough Diagnostics with Nanotechnology